<DOC>
	<DOCNO>NCT02164214</DOCNO>
	<brief_summary>TWEAK ( TNF weakly inducer apoptosis ) type II-transmembrane protein , member TNF ligand superfamily cleave function soluble cytokine . Depending target cell type , TWEAK trigger multiple cellular response range modulation inflammation cell death bind main receptor , Fn 14 . Our team first describe pro-inflammatory effect TWEAK central nervous system inflammation . Various data support possibility TWEAK produce synovial macrophage may contribute chronic synovitis animal model human . In psoriatic arthritis ( PsoA ) , anti-TNF therapy successful concord key role TNF pathogenesis disease generation psoriatic patient neutralize anti-TNF autoantibody refer `` beneficial autoimmunity pro-inflammatory mediator '' . In 2010 , Van Kuijk et al . describe high expression TWEAK inflammatory synovial PsoA rheumatoid arthritis ( RA ) patient anti-TNF therapy . The role TNF-alpha regulation TWEAK expression remain unclear .</brief_summary>
	<brief_title>Does Etanercept Influence Tweak Modulation Inflammation During Inflammatory Rheumatisms ( Psoriatic Arthritis Rheumatoid Arthritis ) ?</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Rheumatic Fever</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>· Group RhPso : Fill ( Perform ) criteria CASPAR Rheumatism psoriasic ( Taylor W , 2006 ) rheumatoid Absence factor antibody antiCCP ( antipost office account ) ( cyclic citrulline peptide ) serum Indication establish begin treatment etanercept · Group PR Fill ( Perform ) criterion ACR ( American College Rheumatology ) PR ( revised 1987 ) ( Arneth FC , 1988 ) Presence antibody antiCCP ( antipost office account ) serum Indication establish begin treatment etanercept Minors ( Miners ) pregnant breastfeed Women Adults guardianship Nobody stay sanitary social establishment Persons emergency situation and/or beneficiary national insurance scheme Private person freedom Arthritis label polyarthritis Contraindication establish treatment ( process ) etanercept PUVAthérapie cyclosporine high dose corticosteroid therapy ( except intraarticular infiltration ) antiTNF treatment ( process ) two month precede inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>